Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atectura Breezhaler 125microg/260microg inhalation pdr caps
0302000X0BBACAC
|
Atectura Breezhaler | Indacaterol/mometasone | Respiratory System | 99 |
|
Atectura Breezhaler 125microg/127.5microg pdr caps
0302000X0BBABAB
|
Atectura Breezhaler | Indacaterol/mometasone | Respiratory System | 55 |
|
Atectura Breezhaler 125microg/62.5microg inhalation pdr caps
0302000X0BBAAAA
|
Atectura Breezhaler | Indacaterol/mometasone | Respiratory System | 5 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.